Clinical Trial Update: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant chemotherapy with nab-paclitaxel, cisplatin, and capecitabine for locally advanced thoracic esophageal squamous cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN